✦ LIBER ✦

Second hematopoietic stem cell transplantation in pediatric patients: Overall survival and long-term follow-up

✍ Scribed by Ami J Shah; Neena Kapoor; Kenneth I Weinberg; Gay M Crooks; Donald B Kohn; Carl Lenarsky; Francine Kaufman; Karen Epport; Kathy Wilson; Robertson Parkman

Book ID: 117816213
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 205 KB
Volume: 8
Category: Article
ISSN: 1083-8791
DOI: 10.1053/bbmt.2002.v8.pm12014811

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Follow-up and Management Guide

Long-Term Follow-up and Management Guidelines in Pediatric Patients After Allogenic Hematopoietic Stem Cell Transplantation

✍ Haydar Frangoul; Jennifer Najjar; Jill Simmons; Jennifer Domm 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Long-Term Follow-Up After Allogeneic Hem

Long-Term Follow-Up After Allogeneic Hematopoietic Progenitor Cell Transplantation In Pediatric Patients-Multicenter Study

✍ E. Gorczynska; A. Dyla; J. Owoc-Lempch; J. Musial; D. Turkiewicz; K. Kalwak; M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Long term disease free survival in patie

Long term disease free survival in patients with mantle cell lymphoma following hematopoietic stem cell transplantation

✍ A.K. Ganti; P.J. Bierman; J.C. Lynch; R.G. Bociek; J.M. Vose; J.O. Armitage 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 54 KB

126: Hematopoietic stem cell transplanta

126: Hematopoietic stem cell transplantation (SCT) in Fanconi Anemia (FA) patients: How long is long term follow-up?

✍ C. Bonfim; M. Bitencourt; C. deMedeiros; D. Setubal; J. Ruiz; M. Quiroga; M. Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Allogenic hematopoietic stem-cell transp

Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma : Long-term follow-up

✍ Avichai Shimoni; Izhar Hardan; Francis Ayuk; Georgia Schilling; Djorde Atanackov 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract ## BACKGROUND: Allogeneic stem cell transplantation (SCT) with myeloablative conditioning is potentially curative therapy for myeloma, but is reportedly associated with a high risk of nonrecurrence mortality (NRM). Reduced‐intensity conditioning (RIC) allows for the reduction of NRM, b

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation With Reduced-Intensity Conditioning In Patients With Refractory And Relapsing Multiple Myeloma: Long-Term Follow-Up

✍ A. Shimoni; I. Hardan; F. Ayuk; G. Schilling; D. Atanackovic; W. Zeller; N. Shem 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 77 KB